These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 31447847)

  • 1. Editorial: Role of CD1- and MR1-Restricted T Cells in Immunity and Disease.
    Iwabuchi K; Van Kaer L
    Front Immunol; 2019; 10():1837. PubMed ID: 31447847
    [No Abstract]   [Full Text] [Related]  

  • 2. CD1, MR1, NKT, and MAIT: evolution and origins of non-peptidic antigen recognition by T lymphocytes.
    Zajonc DM; Flajnik MF
    Immunogenetics; 2016 Aug; 68(8):489-90. PubMed ID: 27480412
    [No Abstract]   [Full Text] [Related]  

  • 3. Editorial: Community series in the role of CD1- and MR1-restricted T cells in immunity and disease, volume II.
    Iwabuchi K; Van Kaer L
    Front Immunol; 2024; 15():1490010. PubMed ID: 39351217
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of CD1d- and MR1-Restricted T Cells in Asthma.
    Iwamura C; Nakayama T
    Front Immunol; 2018; 9():1942. PubMed ID: 30210497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD1 and MR1 recognition by human γδ T cells.
    Van Rhijn I; Le Nours J
    Mol Immunol; 2021 May; 133():95-100. PubMed ID: 33636434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biology of CD1- and MR1-restricted T cells.
    Salio M; Silk JD; Jones EY; Cerundolo V
    Annu Rev Immunol; 2014; 32():323-66. PubMed ID: 24499274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid and small-molecule display by CD1 and MR1.
    Van Rhijn I; Godfrey DI; Rossjohn J; Moody DB
    Nat Rev Immunol; 2015 Oct; 15(10):643-54. PubMed ID: 26388332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD1d- and MR1-restricted invariant T cells: of mice and men.
    Treiner E; Lantz O
    Curr Opin Immunol; 2006 Oct; 18(5):519-26. PubMed ID: 16870416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosal-associated invariant T cell receptor recognition of small molecules presented by MR1.
    Awad W; Le Nours J; Kjer-Nielsen L; McCluskey J; Rossjohn J
    Immunol Cell Biol; 2018 Jul; 96(6):588-597. PubMed ID: 29393543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD1-MR1 EMBO workshop: Beyond MHC-restricted lymphocytes, Oxford September 2019.
    Klenerman P; Ogg G; Salio M
    Mol Immunol; 2021 Jun; 134():170-171. PubMed ID: 33780684
    [No Abstract]   [Full Text] [Related]  

  • 11. Biased MAIT TCR Usage Poised for Limited Antigen Diversity?
    Souter MNT; Eckle SBG
    Front Immunol; 2020; 11():1845. PubMed ID: 33013835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Diverse Family of MR1-Restricted T Cells.
    Gherardin NA; McCluskey J; Rossjohn J; Godfrey DI
    J Immunol; 2018 Nov; 201(10):2862-2871. PubMed ID: 30397170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MR1-restricted T cells: the new dawn of cancer immunotherapy.
    Wang Z; Wang M; Chen J; Zhang L; Zhang L; Yu L
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33185693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MAIT cells and MR1-antigen recognition.
    Keller AN; Corbett AJ; Wubben JM; McCluskey J; Rossjohn J
    Curr Opin Immunol; 2017 Jun; 46():66-74. PubMed ID: 28494326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human T cells use CD1 and MR1 to recognize lipids and small molecules.
    Layre E; de Jong A; Moody DB
    Curr Opin Chem Biol; 2014 Dec; 23():31-8. PubMed ID: 25271021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Immunology of CD1- and MR1-Restricted T Cells.
    Mori L; Lepore M; De Libero G
    Annu Rev Immunol; 2016 May; 34():479-510. PubMed ID: 26927205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MR1-dependent antigen presentation.
    Karamooz E; Harriff MJ; Lewinsohn DM
    Semin Cell Dev Biol; 2018 Dec; 84():58-64. PubMed ID: 30449535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human TRAV1-2-negative MR1-restricted T cells detect S. pyogenes and alternatives to MAIT riboflavin-based antigens.
    Meermeier EW; Laugel BF; Sewell AK; Corbett AJ; Rossjohn J; McCluskey J; Harriff MJ; Franks T; Gold MC; Lewinsohn DM
    Nat Commun; 2016 Aug; 7():12506. PubMed ID: 27527800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural Killer T Cells and Mucosal-Associated Invariant T Cells in Lung Infections.
    Trottein F; Paget C
    Front Immunol; 2018; 9():1750. PubMed ID: 30116242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How MR1 Presents a Pathogen Metabolic Signature to Mucosal-Associated Invariant T (MAIT) Cells.
    McWilliam HEG; Villadangos JA
    Trends Immunol; 2017 Sep; 38(9):679-689. PubMed ID: 28688841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.